Risk factors of urinary tract infection caused by extended spectrum &bgr;‐lactamase‐producing Escherichia coli in emergency department
Abstract
Objectives The incidence of urinary tract infection (UTI) due to extended‐spectrum &bgr;‐lactamase (ESBL)‐producing Escherichia coli has increased over recent years. Initial empirical therapy is often ineffective for these resistant isolates resulting in prolonged hospitalization and increased mortality. This study was conducted to determine the risk factors of UTI caused by ESBL E. coli in the emergency department (ED). Methods This is a retrospective case‐control study at a university hospital in Korea with UTI patients who visited ED between June 2015 and December 2016. We compared case patients with ESBL E. coli UTI (n = 50) to control patients with non‐ESBL‐producing E. coli UTI (n = 100), which were matched for age and sex. Multivariate logistic regression analysis was used to explore risk factors. Results Our study showed that hospital‐acquired infection (OR = 3.86; 95% CI = 1.26–11.8; p = .017), prior UTI within 1 year (OR = 3.26; 95% CI = 1.32–8.05; p = .010), and underlying cerebrovascular disease (OR = 3.24; 95% CI = 1.45–7.25; p = .004) were independent risk factors for acquisition of ESBL‐producing E. coli. Notably, 35 (70%) out of 50 case patients had community‐acquired infection, and 68% and 54% of ESBL E. coli were resistance to ciprofloxacin and trimethoprim‐sulfamethoxazole, respectively. On the contrary, 98% of ESBL E. coli was susceptible to amikacin. Conclusion The main risk factors identified in our study should be considered when treating UTI patients…
Read the paper
Related studies
- Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes
- Mutation supply and relative fitness shape the genotypes of ciprofloxacin-resistant Escherichia coli
- Genomic Survey of E. coli From the Bladders of Women With and Without Lower Urinary Tract Symptoms
- Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017–18
- Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli
- Emerging evidence-based innovative approaches to control catheter-associated urinary tract infection: a review
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.